CJC-1295 (No DAC) Results Timeline
What the standard CJC-1295 (No DAC) research protocol looks like phase by phase, over a typical 8–16 weeks cycle. This is the escalation schedule from our full dosing protocol, presented as a timeline rather than a table.
Quick Facts
FREQUENCYOnce daily
CYCLE LENGTH8–16 weeks
DOSE RANGE100–300 mcg/day
ROUTESubcutaneous injection
Phase-by-Phase Timeline
Loading / Titration
Weeks 1–2
Target dose: 100 mcg
Escalation
Weeks 3–4
Target dose: 200 mcg
Maintenance
Weeks 5+
Target dose: 300 mcg
Reported in Research
- ✓8–12 weeks, then 4-week break.
This timeline reflects the structure of the standard CJC-1295 (No DAC) research protocol documented on this site — it is not a guarantee of individual outcomes, and timelines vary between research subjects. All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.